Evidence map›Paper›PMID 26091668›Full record

ArticleActa neuropathologica communications2015

DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status.

Adam Cohen, Mariko Sato, Kenneth Aldape, Clinton C Mason, Kristin Alfaro-Munoz, Lindsey Heathcock, Sarah T South, Lisa M Abegglen, Joshua D Schiffman, Howard Colman

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Tumor Volume Growth Rates and Doubling Times during Active Surveillance of IDH-mutant Low-Grade Glioma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Chromosomal instability in adult-type diffuse gliomas.Acta neuropathologica communications · 2022
    Review
  16. Article
  17. Article
  18. Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System.Laboratory investigation; a journal of technical methods and pathology · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Adam CohenHuntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT, 84112, USA. adam.cohen@hci.utah.edu.
Mariko SatoChildren's Hospital, University of Iowa, 200 Hawkins Dr, 2524 JCP, Iowa City, IA, 52242, USA. mariko-sato@uiowa.edu.
Kenneth AldapeDepartment of Pathology, MD Anderson Cancer Center, Houston, TX, 77030, USA. Ken.Aldape@uhn.ca.
Clinton C MasonHuntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT, 84112, USA. Clint.Mason@hci.utah.edu.
Kristin Alfaro-MunozDepartment of Pathology, MD Anderson Cancer Center, Houston, TX, 77030, USA. KDAlfaro@mdanderson.org.
Lindsey HeathcockDepartment of Pathology, MD Anderson Cancer Center, Houston, TX, 77030, USA. heathcoc@bcm.edu.
Sarah T SouthARUP Laboratories, Salt Lake City, UT, 84112, USA. Sarah.South@hsc.utah.edu.
Lisa M AbegglenHuntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT, 84112, USA. Lisa.Abegglen@hci.utah.edu.
Joshua D SchiffmanHuntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT, 84112, USA. joshua.schiffman@hci.utah.edu.
Howard ColmanHuntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT, 84112, USA. Howard.Colman@hci.utah.edu.
Huntsman Cancer Institute · USThe University of Texas MD Anderson Cancer Center · USUniversity of Utah · USARUP Laboratories (United States) · USUniversity of Iowa Stead Family Children’s Hospital · US

Funding

Tropism Enhanced Oncolytic Adenovirus for the Treatment of Brain TumorsP50CA127001 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Juan Fueyo · 2008 to 2026
$41.2M
NCI NIH HHS 5P50 CA127001NCI NIH HHS P50 CA127001
6 · The paper itself

Abstract

introductionIsocitrate dehydrogenase (IDH) mutation status and grade define subgroups of diffuse gliomas differing based on age, tumor location, presentation, and prognosis. While some biologic differences between IDH mutated (IDH (mut)) and wild-type (IDH (wt)) gliomas are clear, the distinct alterations associated with progression of the two subtypes to glioblastoma (GBM, Grade IV) have not been well described. We analyzed copy number alterations (CNAs) across grades (Grade II-III and GBM) in both IDH (mut) and IDH (wt) infiltrating gliomas using molecular inversion probe arrays.

resultsNinety four patient samples were divided into four groups: Grade II-III IDH (wt) (n = 17), Grade II-III IDH (mut) (n = 28), GBM IDH (wt) (n = 25), and GBM IDH (mut) (n = 24). We validated prior observations that IDH (wt) GBM have a high frequency of chromosome 7 gain (including EGFR) and chromosome 10 loss (including PTEN) compared with IDH (mut) GBM. Hierarchical clustering of IDH (mut) gliomas demonstrated distinct CNA patterns distinguishing lower grade gliomas versus GBM. However, similar hierarchical clustering of IDH (wt) gliomas demonstrated no CNA distinction between lower grade glioma and GBM. Functional analyses showed that IDH (wt) gliomas had more chromosome gains in regions containing receptor tyrosine kinase pathways. In contrast, IDH (mut) gliomas more commonly demonstrated amplification of cyclins and cyclin dependent kinase genes. One of the most common alterations associated with transformation of lower grade to GBM IDH (mut) gliomas was the loss of chromosomal regions surrounding PTEN. IDH (mut) GBM tumors demonstrated significantly higher levels of overall CNAs compared to lower grade IDH (mut) tumors and all grades of IDH (wt) tumors, and IDH (mut) GBMs also demonstrated significant increase in incidence of chromothripsis.

conclusionsTaken together, these analyses demonstrate distinct molecular ontogeny between IDH (wt) and IDH (mut) gliomas. Our data also support the novel findings that malignant progression of IDH (mut) gliomas to GBM involves increased genomic instability and genomic catastrophe, while IDH (wt) lower grade tumors are virtually identical to GBMs at the level of DNA copy number alterations.

Indexed as

Brain NeoplasmsChromosomal InstabilityChromosome MappingChromosomes, Human, Pair 10Cohort StudiesDisease ProgressionDNA Copy Number VariationsFemaleGene Expression Regulation, NeoplasticGene OntologyGliomaHumansIsocitrate DehydrogenaseMaleSurvival AnalysisIsocitrate Dehydrogenase

Identifiers

PMID26091668
PMCPMC4474351
OpenAlexW1881100945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.